دورية أكاديمية
Female Pattern Hair Loss and Negative Psychological Impact: Possible Role of Brain-derived Neurotrophic Factor (BDNF).
| العنوان: | Female Pattern Hair Loss and Negative Psychological Impact: Possible Role of Brain-derived Neurotrophic Factor (BDNF). |
|---|---|
| المؤلفون: | Mohamed NE; Department of Dermatology, STDs, and Andrology, Faculty of Medicine Fayoum University, Faiyum, Egypt., Soltan MR; Psychiatry Department, Fayoum University, Faiyum, Egypt., Galal SA; Dermatology and Venereology Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt., El Sayed HS; Medical Biochemistry and Molecular Biology, Faculty of Medicine Fayoum University, Egypt The research was conducted in the outpatient clinic of the Department of Dermatology, STDs, and Andrology, Faculty of Medicine, Fayoum University., Hassan HM; Department of Dermatology, STDs, and Andrology, Faculty of Medicine Fayoum University, Faiyum, Egypt., Khatery BH; Department of Dermatology, STDs, and Andrology, Faculty of Medicine Fayoum University, Faiyum, Egypt. |
| المصدر: | Dermatology practical & conceptual [Dermatol Pract Concept] 2023 Jul 01; Vol. 13 (3). Date of Electronic Publication: 2023 Jul 01. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: International Dermoscopy Society Country of Publication: Austria NLM ID: 101585990 Publication Model: Electronic Cited Medium: Print ISSN: 2160-9381 (Print) Linking ISSN: 21609381 NLM ISO Abbreviation: Dermatol Pract Concept Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Publication: Graz, Austria : International Dermoscopy Society Original Publication: New York : Derm101.com |
| مستخلص: | Introduction: Female Pattern Hair Loss (FPHL) is considered the most common type of hair loss in females. Women with FPHL may suffer from psychological distress and defective social functioning. Patients with psychiatric and neurodegenerative disorders almost have a deficient brain and blood brain-derived neurotrophic factor levels (BDNF). This serum BDNF level may act as a diagnostic marker for negative psychological impact in FPHL patients. Objectives: Evaluate the levels of serum BDNF in patients with FPHL and correlate its level to the severity of alopecia and the degree of psychological impact. Methods: Forty-six female patients with FPHL and 41 healthy age-matched female volunteers as a control were included in the study. Patients filled out a Dermatology Life Quality Index questionnaire. Both patients and controls filled Beck Depression Inventory, Beck Anxiety Inventory, and Perceived Stress Scale (PSS) questionnaires. Serum levels of BDNF were measured for all the participants using the ELISA technique. Results: Patients with FPHL had significantly lower levels of BDNF and significantly higher Beck depression inventory score and PSS questionnaire scores. There is a significant negative correlation between serum levels of BDNF and Beck Depression Inventory, Beck Anxiety Inventory, and PSS questionnaire scores. Conclusions: Patients with FPHL are at a high risk to develop chronic stress and depression. The serum level of BDNF is a good predictor for the assessment of chronic stress and depression in FPHL patients. |
| References: | J Clin Endocrinol Metab. 2019 Jul 1;104(7):2875-2891. (PMID: 30785992) Int J Trichology. 2012 Jan;4(1):23-8. (PMID: 22628986) Int J Womens Dermatol. 2018 Jun 19;4(4):203-211. (PMID: 30627618) Cleve Clin J Med. 2021 Mar 1;88(3):173-182. (PMID: 33648970) Int J Cosmet Sci. 2016 Dec;38(6):651-654. (PMID: 27163333) Pharmacol Rev. 2012 Apr;64(2):238-58. (PMID: 22407616) Exp Dermatol. 2017 Jun;26(6):510-517. (PMID: 28453904) J Invest Dermatol. 2005 Apr;124(4):675-85. (PMID: 15816823) Br J Dermatol. 2011 Nov;165(5):997-1002. (PMID: 21729031) Aust J Gen Pract. 2018 Jul;47(7):459-464. (PMID: 30114864) J Am Acad Dermatol. 2019 Jun;80(6):1497-1506. (PMID: 30312644) J Health Soc Behav. 1983 Dec;24(4):385-96. (PMID: 6668417) Int J Womens Dermatol. 2018 Jan 09;4(1):18-22. (PMID: 29872671) Postepy Dermatol Alergol. 2021 Oct;38(5):815-818. (PMID: 34849129) J Eur Acad Dermatol Venereol. 2016 Apr;30(4):667-76. (PMID: 26676524) Neuropsychiatr Dis Treat. 2014 Dec 12;10:2361-7. (PMID: 25540586) PLoS One. 2018 Jun 29;13(6):e0199750. (PMID: 29958268) Med Arch. 2018 Apr;72(2):136-140. (PMID: 30302033) J Invest Dermatol. 2006 Aug;126(8):1719-27. (PMID: 16845411) Mol Neurobiol. 2018 Aug;55(8):6939-6955. (PMID: 29372544) An Bras Dermatol. 2019 Oct 17;94(4):486-487. (PMID: 31644631) J Eur Acad Dermatol Venereol. 2002 Sep;16(5):476-80. (PMID: 12428841) Health Qual Life Outcomes. 2005 May 20;3:36. (PMID: 15907211) |
| تواريخ الأحداث: | Date Created: 20230809 Latest Revision: 20230812 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC10412050 |
| DOI: | 10.5826/dpc.1303a139 |
| PMID: | 37557155 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!